MoneyWorks4Me

Shilpa Medicare informs about disclosure

09 Aug 2023 Evaluate
Shilpa Medicare has informed that it enclosed disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August 09, 2023 for Ramakant Innani, on behalf of Promoters.

The above information is a part of company’s filings submitted to BSE

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..